MedicinePharmacologyPharmacotherapyDementiaNeurodegenerationNeuropharmacologyDementia PharmacotherapyDementia TreatmentNeurodegenerative Disease PharmacotherapyNeurodegenerative DiseasesNeurovascular DysfunctionVascular DementiaCell Damage MechanismsCerebral Ischemia PharmacotherapyMedication Review In DementiaPharmacological TherapyPharmacological Treatment Of DementiaValidation TherapyVascular Dementia CareVascular Dementia Pharmacotherapy
Vascular dementia is a common condition for which there are no effective approved pharmacological treatments available. Absence of effective treatments creates a difficult situation for those suffering from the disease, their caregivers, and healthcare providers. This review will address our current understanding of the mechanisms of nerve cell damage due to ischemia and summarize available clinical trial data on several commonly used compounds including memantine, donepezil, galantamine, rivastigmine, nimodipine, hydergine, nicergoline, CDP-choline, folic acid, as well as such nonpharmacological approaches as validation therapy.
22
Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia
Jean‐Marc Orgogozo, Anne‐Sophie Rigaud, Albrecht Stöffler et al. · Stroke · 2002 · 538 citations